Adjuvante medikamentöse Therapie des Prostatakarzinoms
Author:
Publisher
Springer-Verlag
Link
http://link.springer.com/content/pdf/10.1007/3-540-26450-7_6.pdf
Reference53 articles.
1. Partin AW, Kattan MW, Subong EN et al. (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277(18): 1445–1451
2. Bolla M, Collette L, Blank L et al. (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360(9327): 103–106
3. Bolla M, Gonzalez D, Warde P et al. (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337(5): 295–300
4. McLeod D, Iversen P, See W, Wirth M (2004) Bicalutamide (Casodex) 150 mg ad adjuvant to radiotherapy significantly improves progression-free survival in early non-metastatic prostate cancer: results from the bicalutamide early prostate cancer programme after a median 5.4 years' follow-up. Eur Urol Suppl 3(2): 48
5. Di Gangi Herms, Alida MR, Stenzl A (2003) Psychosoziale Betreuung und psychologische Intervention in der Urologie: der Uropsychologische Dienst. Psychologische Medizin, (14)2: 17–23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3